BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19022738)

  • 1. Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G.
    Chelico L; Pham P; Goodman MF
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):583-93. PubMed ID: 19022738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of phosphorylation and phosphorylation-null mutants on the activity and deamination specificity of activation-induced cytidine deaminase.
    Pham P; Smolka MB; Calabrese P; Landolph A; Zhang K; Zhou H; Goodman MF
    J Biol Chem; 2008 Jun; 283(25):17428-39. PubMed ID: 18417471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants.
    Mu Y; Prochnow C; Pham P; Chen XS; Goodman MF
    J Biol Chem; 2012 Aug; 287(33):28007-16. PubMed ID: 22715099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AID and Apobec3G haphazard deamination and mutational diversity.
    Jaszczur M; Bertram JG; Pham P; Scharff MD; Goodman MF
    Cell Mol Life Sci; 2013 Sep; 70(17):3089-108. PubMed ID: 23178850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin Class Switch Recombination Is Initiated by Rare Cytosine Deamination Events at Switch Regions.
    Kim A; Han L; Yu K
    Mol Cell Biol; 2020 Jul; 40(16):. PubMed ID: 32513818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The APOBEC-2 crystal structure and functional implications for the deaminase AID.
    Prochnow C; Bransteitter R; Klein MG; Goodman MF; Chen XS
    Nature; 2007 Jan; 445(7126):447-51. PubMed ID: 17187054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
    Love RP; Xu H; Chelico L
    J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
    Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
    PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation.
    Pham P; Bransteitter R; Petruska J; Goodman MF
    Nature; 2003 Jul; 424(6944):103-7. PubMed ID: 12819663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.
    Ouadani H; Ben-Mustapha I; Ben-Ali M; Larguèche B; Jovanic T; Garcia S; Arcangioli B; Elloumi-Zghal H; Fathallah D; Hachicha M; Masmoudi H; Rougeon F; Barbouche MR
    Mol Immunol; 2016 Nov; 79():77-82. PubMed ID: 27716525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
    Kohli RM; Maul RW; Guminski AF; McClure RL; Gajula KS; Saribasak H; McMahon MA; Siliciano RF; Gearhart PJ; Stivers JT
    J Biol Chem; 2010 Dec; 285(52):40956-64. PubMed ID: 20929867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice.
    Cheng HL; Vuong BQ; Basu U; Franklin A; Schwer B; Astarita J; Phan RT; Datta A; Manis J; Alt FW; Chaudhuri J
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2717-22. PubMed ID: 19196992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase.
    Bransteitter R; Pham P; Calabrese P; Goodman MF
    J Biol Chem; 2004 Dec; 279(49):51612-21. PubMed ID: 15371439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation-induced cytidine deaminase targets SUV4-20-mediated histone H4K20 trimethylation to class-switch recombination sites.
    Rodríguez-Cortez VC; Martínez-Redondo P; Català-Moll F; Rodríguez-Ubreva J; Garcia-Gomez A; Poorani-Subramani G; Ciudad L; Hernando H; Pérez-García A; Company C; Urquiza JM; Ramiro AR; Di Noia JM; Vaquero A; Ballestar E
    Sci Rep; 2017 Aug; 7(1):7594. PubMed ID: 28790320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
    Kohli RM; Abrams SR; Gajula KS; Maul RW; Gearhart PJ; Stivers JT
    J Biol Chem; 2009 Aug; 284(34):22898-904. PubMed ID: 19561087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S; Zlotnick A
    J Virol; 2018 May; 92(10):. PubMed ID: 29491156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
    Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
    Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation protects cytidines from AID-mediated deamination.
    Larijani M; Frieder D; Sonbuchner TM; Bransteitter R; Goodman MF; Bouhassira EE; Scharff MD; Martin A
    Mol Immunol; 2005 Mar; 42(5):599-604. PubMed ID: 15607819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.